Summary
Datamonitor's Elan Corporation, plc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Elan is a neuroscience based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain. The company's therapeutic emphasis is on the areas of neurology, autoimmune disease and severe pain. Elan is headquartered in Dublin, Ireland and employed 1,734 people as of December 31, 2006. The company recorded revenues of $759.4million during the fiscal year ended December 2007, an increase of 35.5% over 2006. The operating loss of the company was $265.3 million during fiscal year 2007, compared to an operating loss of $166.4 million in 2006. The net loss was $405 million in fiscal year 2007, compared to a net loss of $267.3 million in 2006. *Financials are unaudited http://www.elan.com/News/full.asp?ID=1107579
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available.
|
